Skip to main content
Top
Published in: BMC Gastroenterology 1/2012

Open Access 01-12-2012 | Research article

A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population

Published in: BMC Gastroenterology | Issue 1/2012

Login to get access

Abstract

Background

The human ATP-binding cassette, subfamily B, member 11 (ABCB11) gene encodes the bile salt export pump, which is exclusively expressed at the canalicular membrane of hepatocytes. A frequent variant in the coding region, c.1331 T > C, leading to the amino acid exchange p.V444A, has been associated with altered serum bile salt levels in healthy individuals and predisposes homozygous carriers of the [C] allele for obstetric cholestasis. Recently, elevated bile salt levels were shown to be significantly associated with rates and risk of cirrhosis in patients with chronic hepatitis C virus (HCV) infection treated with pegylated interferon-α2 and ribavirin, suggesting a potential role for bile salt levels in HCV treatment outcomes and in the fibrogenic evolution of HCV-related liver disease. The aim of this study was to investigate a possible association of ABCB11 c.1331 T > C with hepatitis C virus (HCV) infection and fibrosis stages as assessed by non-invasive transient elastography in a German cohort of patients.

Methods

ABCB11 c.1331 T > C genotype was determined by allelic discrimination assay in 649 HCV infected cases and 413 controls. Overall, 444 cases were staged for fibrotic progression by measurement of liver stiffness.

Results

Homo- or heterozygous presence of the frequent [C] allele was associated with HCV positivity (OR = 1.41, CI = 1.02 - 1.95, p = 0.037). No association was detectable between the ABCB11 c.1331 T > C genotype and increased liver stiffness.

Conclusions

Our data confirm that homozygous presence of the major [C] allele of ABCB11 c.1331 T > C is a genetic susceptibility factor for HCV infection, but not for liver fibrosis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Offergeld R, Ritter S, Quabeck L, Hamouda O: Epidemiological data on infections among blood donors in Germany 2007. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010, 53 (11): 1188-1196. 10.1007/s00103-010-1152-6.CrossRefPubMed Offergeld R, Ritter S, Quabeck L, Hamouda O: Epidemiological data on infections among blood donors in Germany 2007. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010, 53 (11): 1188-1196. 10.1007/s00103-010-1152-6.CrossRefPubMed
2.
go back to reference Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M, Kruska L, Hensel F, Petry W, et al: Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998, 28 (6): 1687-1695. 10.1002/hep.510280632.CrossRefPubMed Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hurter D, Nawrocki M, Kruska L, Hensel F, Petry W, et al: Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998, 28 (6): 1687-1695. 10.1002/hep.510280632.CrossRefPubMed
3.
4.
go back to reference Sheehan MM, Doyle CT, Whelton M, Kenny-Walsh E: Hepatitis C virus liver disease in women infected with contaminated anti-D immunoglobulin. Histopathology. 1997, 30 (6): 512-517. 10.1046/j.1365-2559.1997.5530803.x.CrossRefPubMed Sheehan MM, Doyle CT, Whelton M, Kenny-Walsh E: Hepatitis C virus liver disease in women infected with contaminated anti-D immunoglobulin. Histopathology. 1997, 30 (6): 512-517. 10.1046/j.1365-2559.1997.5530803.x.CrossRefPubMed
5.
go back to reference Fanning LJ: The Irish paradigm on the natural progression of hepatitis C virus infection: an investigation in a homogeneous patient population infected with HCV 1b (review). Int J Mol Med. 2002, 9 (2): 179-184.PubMed Fanning LJ: The Irish paradigm on the natural progression of hepatitis C virus infection: an investigation in a homogeneous patient population infected with HCV 1b (review). Int J Mol Med. 2002, 9 (2): 179-184.PubMed
6.
go back to reference Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK: Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol. 2004, 72 (1): 60-65. 10.1002/jmv.10533.CrossRefPubMed Goyal A, Kazim SN, Sakhuja P, Malhotra V, Arora N, Sarin SK: Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol. 2004, 72 (1): 60-65. 10.1002/jmv.10533.CrossRefPubMed
7.
go back to reference Hohler T, Kruger A, Gerken G, Schneider PM, Büschenfelde KH Meyer zum, Rittner C: Tumor necrosis factor alpha promoter polymorphism at position −238 is associated with chronic active hepatitis C infection. J Med Virol. 1998, 54 (3): 173-177. 10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2.CrossRefPubMed Hohler T, Kruger A, Gerken G, Schneider PM, Büschenfelde KH Meyer zum, Rittner C: Tumor necrosis factor alpha promoter polymorphism at position −238 is associated with chronic active hepatitis C infection. J Med Virol. 1998, 54 (3): 173-177. 10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2.CrossRefPubMed
8.
go back to reference Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, Zaman A, Taylor K, Chou S: Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol. 2002, 97 (3): 714-720. 10.1111/j.1572-0241.2002.05552.x.CrossRefPubMed Rosen HR, McHutchison JG, Conrad AJ, Lentz JJ, Marousek G, Rose SL, Zaman A, Taylor K, Chou S: Tumor necrosis factor genetic polymorphisms and response to antiviral therapy in patients with chronic hepatitis C. Am J Gastroenterol. 2002, 97 (3): 714-720. 10.1111/j.1572-0241.2002.05552.x.CrossRefPubMed
9.
go back to reference Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA: Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology. 2001, 33 (3): 708-712. 10.1053/jhep.2001.22347.CrossRefPubMed Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA: Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology. 2001, 33 (3): 708-712. 10.1053/jhep.2001.22347.CrossRefPubMed
10.
go back to reference Bosi I, Ancora G, Mantovani W, Miniero R, Verucchi G, Attard L, Venturi V, Papa I, Sandri F, Dallacasa P, et al: HLA DR13 and HCV vertical infection. Pediatr Res. 2002, 51 (6): 746-749. 10.1203/00006450-200206000-00014.CrossRefPubMed Bosi I, Ancora G, Mantovani W, Miniero R, Verucchi G, Attard L, Venturi V, Papa I, Sandri F, Dallacasa P, et al: HLA DR13 and HCV vertical infection. Pediatr Res. 2002, 51 (6): 746-749. 10.1203/00006450-200206000-00014.CrossRefPubMed
11.
go back to reference Vejbaesya S, Songsivilai S, Tanwandee T, Rachaibun S, Chantangpol R, Dharakul T: HLA association with hepatitis C virus infection. Hum Immunol. 2000, 61 (3): 348-353. 10.1016/S0198-8859(99)00131-7.CrossRefPubMed Vejbaesya S, Songsivilai S, Tanwandee T, Rachaibun S, Chantangpol R, Dharakul T: HLA association with hepatitis C virus infection. Hum Immunol. 2000, 61 (3): 348-353. 10.1016/S0198-8859(99)00131-7.CrossRefPubMed
12.
go back to reference Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, Airoldi A, Salvaneschi L, Mondelli MU, Ideo G: Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol. 1998, 28 (1): 1-7.CrossRefPubMed Zavaglia C, Martinetti M, Silini E, Bottelli R, Daielli C, Asti M, Airoldi A, Salvaneschi L, Mondelli MU, Ideo G: Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. J Hepatol. 1998, 28 (1): 1-7.CrossRefPubMed
13.
go back to reference Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U: Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology. 2002, 122 (7): 1721-1728. 10.1053/gast.2002.33660.CrossRefPubMed Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U: Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology. 2002, 122 (7): 1721-1728. 10.1053/gast.2002.33660.CrossRefPubMed
14.
go back to reference Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, et al: A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007, 46 (2): 297-306. 10.1002/hep.21695.CrossRefPubMed Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, et al: A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007, 46 (2): 297-306. 10.1002/hep.21695.CrossRefPubMed
15.
go back to reference Marcolongo M, Young B, Dal Pero F, Fattovich G, Peraro L, Guido M, Sebastiani G, Palu G, Alberti A: A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology. 2009, 50 (4): 1038-1044. 10.1002/hep.23111.CrossRefPubMed Marcolongo M, Young B, Dal Pero F, Fattovich G, Peraro L, Guido M, Sebastiani G, Palu G, Alberti A: A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology. 2009, 50 (4): 1038-1044. 10.1002/hep.23111.CrossRefPubMed
16.
go back to reference Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C: Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics. 2007, 17 (1): 47-60. 10.1097/01.fpc.0000230418.28091.76.CrossRefPubMed Lang C, Meier Y, Stieger B, Beuers U, Lang T, Kerb R, Kullak-Ublick GA, Meier PJ, Pauli-Magnus C: Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury. Pharmacogenet Genomics. 2007, 17 (1): 47-60. 10.1097/01.fpc.0000230418.28091.76.CrossRefPubMed
17.
go back to reference Dixon PH, van Mil SW, Chambers J, Strautnieks S, Thompson RJ, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson LA, et al: Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut. 2009, 58 (4): 537-544. 10.1136/gut.2008.159541.CrossRefPubMed Dixon PH, van Mil SW, Chambers J, Strautnieks S, Thompson RJ, Lammert F, Kubitz R, Keitel V, Glantz A, Mattsson LA, et al: Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut. 2009, 58 (4): 537-544. 10.1136/gut.2008.159541.CrossRefPubMed
18.
go back to reference Meier Y, Zodan T, Lang C, Zimmermann R, Kullak-Ublick GA, Meier PJ, Stieger B, Pauli-Magnus C: Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331 T > C polymorphism in the bile salt export pump. World J Gastroenterol. 2008, 14 (1): 38-45. 10.3748/wjg.14.38.CrossRefPubMedPubMedCentral Meier Y, Zodan T, Lang C, Zimmermann R, Kullak-Ublick GA, Meier PJ, Stieger B, Pauli-Magnus C: Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331 T > C polymorphism in the bile salt export pump. World J Gastroenterol. 2008, 14 (1): 38-45. 10.3748/wjg.14.38.CrossRefPubMedPubMedCentral
19.
go back to reference Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ: The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem. 1998, 273 (16): 10046-10050. 10.1074/jbc.273.16.10046.CrossRefPubMed Gerloff T, Stieger B, Hagenbuch B, Madon J, Landmann L, Roth J, Hofmann AF, Meier PJ: The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem. 1998, 273 (16): 10046-10050. 10.1074/jbc.273.16.10046.CrossRefPubMed
20.
go back to reference Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, et al: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998, 20 (3): 233-238. 10.1038/3034.CrossRefPubMed Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, et al: A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet. 1998, 20 (3): 233-238. 10.1038/3034.CrossRefPubMed
21.
go back to reference Ho RH, Leake BF, Kilkenny DM, Meyer Zu Schwabedissen HE, Glaeser H, Kroetz DL, Kim RB: Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics. 2010, 20 (1): 45-57. 10.1097/FPC.0b013e3283349eb0.CrossRefPubMedPubMedCentral Ho RH, Leake BF, Kilkenny DM, Meyer Zu Schwabedissen HE, Glaeser H, Kroetz DL, Kim RB: Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability. Pharmacogenet Genomics. 2010, 20 (1): 45-57. 10.1097/FPC.0b013e3283349eb0.CrossRefPubMedPubMedCentral
22.
go back to reference Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, Nussler N, Eichelbaum M, Meier PJ, Stieger B: Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology. 2006, 44 (1): 62-74.CrossRefPubMed Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, Nussler N, Eichelbaum M, Meier PJ, Stieger B: Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatology. 2006, 44 (1): 62-74.CrossRefPubMed
23.
go back to reference Iwata R, Stieger B, Mertens JC, Muller T, Baur K, Frei P, Braun J, Vergopoulos A, Martin IV, Schmitt J, et al: The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C. J Viral Hepat. 2011, 18 (11): 768-778. 10.1111/j.1365-2893.2010.01363.x.CrossRefPubMed Iwata R, Stieger B, Mertens JC, Muller T, Baur K, Frei P, Braun J, Vergopoulos A, Martin IV, Schmitt J, et al: The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C. J Viral Hepat. 2011, 18 (11): 768-778. 10.1111/j.1365-2893.2010.01363.x.CrossRefPubMed
24.
go back to reference Iwata R, Baur K, Stieger B, Mertens JC, Daly AK, Frei P, Braun J, Vergopoulos A, Stickel F, Sabrane K, et al: A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond). 2010, 120 (7): 287-296.CrossRef Iwata R, Baur K, Stieger B, Mertens JC, Daly AK, Frei P, Braun J, Vergopoulos A, Stickel F, Sabrane K, et al: A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond). 2010, 120 (7): 287-296.CrossRef
25.
go back to reference Krawczyk M, Grünhage F, Zimmer V, Lammert F: Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J Hepatol. 2011, 55 (2): 299-306. 10.1016/j.jhep.2010.10.042.CrossRefPubMed Krawczyk M, Grünhage F, Zimmer V, Lammert F: Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: non-invasive elastography-based study in chronic liver disease. J Hepatol. 2011, 55 (2): 299-306. 10.1016/j.jhep.2010.10.042.CrossRefPubMed
26.
go back to reference Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E: Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008, 134 (4): 960-974. 10.1053/j.gastro.2008.01.034.CrossRefPubMed Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E: Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008, 134 (4): 960-974. 10.1053/j.gastro.2008.01.034.CrossRefPubMed
27.
go back to reference Nojiri S, Nakao H, Sugauchi F, Miyaki T, Senda K, Sasaki M, Kataoka H, Kamiya T, Nakazawa T, Ohara H, et al: Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection. Hepatol Res. 2009, 39 (1): 21-30. 10.1111/j.1872-034X.2008.00406.x.CrossRefPubMed Nojiri S, Nakao H, Sugauchi F, Miyaki T, Senda K, Sasaki M, Kataoka H, Kamiya T, Nakazawa T, Ohara H, et al: Effect of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis C virus infection. Hepatol Res. 2009, 39 (1): 21-30. 10.1111/j.1872-034X.2008.00406.x.CrossRefPubMed
28.
go back to reference Omata M, Yoshida H, Toyota J, Tomita E, Nishiguchi S, Hayashi N, Iino S, Makino I, Okita K, Toda G, et al: A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. Gut. 2007, 56 (12): 1747-1753. 10.1136/gut.2007.120956.CrossRefPubMedPubMedCentral Omata M, Yoshida H, Toyota J, Tomita E, Nishiguchi S, Hayashi N, Iino S, Makino I, Okita K, Toda G, et al: A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C. Gut. 2007, 56 (12): 1747-1753. 10.1136/gut.2007.120956.CrossRefPubMedPubMedCentral
29.
go back to reference Sato S, Miyake T, Tobita H, Oshima N, Ishine J, Hanaoka T, Amano Y, Kinoshita Y: A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. World J Gastroenterol. 2009, 15 (22): 2782-2786. 10.3748/wjg.15.2782.CrossRefPubMedPubMedCentral Sato S, Miyake T, Tobita H, Oshima N, Ishine J, Hanaoka T, Amano Y, Kinoshita Y: A dose-up of ursodeoxycholic acid decreases transaminases in hepatitis C patients. World J Gastroenterol. 2009, 15 (22): 2782-2786. 10.3748/wjg.15.2782.CrossRefPubMedPubMedCentral
30.
go back to reference Chang KO, George DW: Bile acids promote the expression of hepatitis C virus in replicon-harboring cells. J Virol. 2007, 81 (18): 9633-9640. 10.1128/JVI.00795-07.CrossRefPubMedPubMedCentral Chang KO, George DW: Bile acids promote the expression of hepatitis C virus in replicon-harboring cells. J Virol. 2007, 81 (18): 9633-9640. 10.1128/JVI.00795-07.CrossRefPubMedPubMedCentral
31.
go back to reference Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thorne A, Nowak G, Ericzon BG, Bjorkhem I, Einarsson C: Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Hepatology. 2003, 38 (4): 930-938.CrossRefPubMed Ellis E, Axelson M, Abrahamsson A, Eggertsen G, Thorne A, Nowak G, Ericzon BG, Bjorkhem I, Einarsson C: Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Hepatology. 2003, 38 (4): 930-938.CrossRefPubMed
32.
go back to reference Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 2000, 6 (3): 507-515. 10.1016/S1097-2765(00)00050-2.CrossRefPubMed Lu TT, Makishima M, Repa JJ, Schoonjans K, Kerr TA, Auwerx J, Mangelsdorf DJ: Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell. 2000, 6 (3): 507-515. 10.1016/S1097-2765(00)00050-2.CrossRefPubMed
33.
go back to reference Scholtes C, Diaz O, Icard V, Kaul A, Bartenschlager R, Lotteau V, Andre P: Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. J Hepatol. 2008, 48 (2): 192-199. 10.1016/j.jhep.2007.09.015.CrossRefPubMed Scholtes C, Diaz O, Icard V, Kaul A, Bartenschlager R, Lotteau V, Andre P: Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. J Hepatol. 2008, 48 (2): 192-199. 10.1016/j.jhep.2007.09.015.CrossRefPubMed
34.
go back to reference Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, Yan QW, Miyoshi H, Mashek DG: The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest. 2011, 121 (6): 2102-2110. 10.1172/JCI46069.CrossRefPubMedPubMedCentral Greenberg AS, Coleman RA, Kraemer FB, McManaman JL, Obin MS, Puri V, Yan QW, Miyoshi H, Mashek DG: The role of lipid droplets in metabolic disease in rodents and humans. J Clin Invest. 2011, 121 (6): 2102-2110. 10.1172/JCI46069.CrossRefPubMedPubMedCentral
35.
go back to reference Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K: The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol. 2007, 9 (9): 1089-1097. 10.1038/ncb1631.CrossRefPubMed Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K: The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol. 2007, 9 (9): 1089-1097. 10.1038/ncb1631.CrossRefPubMed
36.
go back to reference Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R: Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008, 4 (3): e1000035-10.1371/journal.ppat.1000035.CrossRefPubMedPubMedCentral Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R: Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008, 4 (3): e1000035-10.1371/journal.ppat.1000035.CrossRefPubMedPubMedCentral
37.
go back to reference Woodhouse SD, Narayan R, Latham S, Lee S, Antrobus R, Gangadharan B, Luo S, Schroth GP, Klenerman P, Zitzmann N: Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology. 2010, 52 (2): 443-453. 10.1002/hep.23733.CrossRefPubMedPubMedCentral Woodhouse SD, Narayan R, Latham S, Lee S, Antrobus R, Gangadharan B, Luo S, Schroth GP, Klenerman P, Zitzmann N: Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro. Hepatology. 2010, 52 (2): 443-453. 10.1002/hep.23733.CrossRefPubMedPubMedCentral
38.
go back to reference Lu Y, Feskens EJ, Boer JM, Muller M: The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population. Atherosclerosis. 2010, 210 (1): 14-27. 10.1016/j.atherosclerosis.2009.10.035.CrossRefPubMed Lu Y, Feskens EJ, Boer JM, Muller M: The potential influence of genetic variants in genes along bile acid and bile metabolic pathway on blood cholesterol levels in the population. Atherosclerosis. 2010, 210 (1): 14-27. 10.1016/j.atherosclerosis.2009.10.035.CrossRefPubMed
39.
go back to reference Henkel AS, Kavesh MH, Kriss MS, Dewey AM, Rinella ME, Green RM: Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice. Gastroenterology. 2011, 141 (4): 1404-1411. 10.1053/j.gastro.2011.06.062. 1411 e1401-1402CrossRefPubMedPubMedCentral Henkel AS, Kavesh MH, Kriss MS, Dewey AM, Rinella ME, Green RM: Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice. Gastroenterology. 2011, 141 (4): 1404-1411. 10.1053/j.gastro.2011.06.062. 1411 e1401-1402CrossRefPubMedPubMedCentral
40.
go back to reference Müllenbach R, Weber SN, Lammert F: Nuclear receptor variants in liver disease. J Lipids. 2012, 2012: 934707-CrossRefPubMed Müllenbach R, Weber SN, Lammert F: Nuclear receptor variants in liver disease. J Lipids. 2012, 2012: 934707-CrossRefPubMed
Metadata
Title
A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population
Publication date
01-12-2012
Published in
BMC Gastroenterology / Issue 1/2012
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-12-63

Other articles of this Issue 1/2012

BMC Gastroenterology 1/2012 Go to the issue